Health Care: Drugs

Acorda Therapeutics Inc (ACOR: NASDAQ)

$34.25 n/a | n/a%
10/24/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 34.25
52 Week High 39.95
52 Week Low 27.51
Avg. Daily Vol. (Mil) 0.70
Beta (3 year) 1.60
Share Related Items
Mkt Cap (Mil) 1,429.76
Shares Out (Mil) 41.74
Float (Mil) 35.61
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.70
Current Ratio 7.30
LT Debt/ Equity 0.57
Total Debt / Equity 0.57
Valuation Ratios
Price Earnings 75.60
Price/Sales 4.03
Price/Book 2.86
Price/Cash Flow 48.00
Per Share Data
Earnings 0.45
Sales 8.51
Book Value 11.99
Cash Flow 0.71
Business Summary
Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.
General Information
420 Saw Mill River Road
Ardsley, NY 10502
Industry : Drugs
Sector: Health Care
Employees: 421
CEO: Ron Cohen,M.D.
Short Interest
Current Month (Mil) 5.92
Previous Month (Mil) 5.60
Short Interest Ratio (Days) 5.00
Management Effectiveness
Return on Equity 3.80
Return on Assets 2.00
Return on Investments 2.40
Gross Margin 83.10
EBIT Margin 11.00
Profit Margin 5.40

Portfolios with ACOR

Latest ACOR Headlines from TheStreet

More Financial News for ACOR

Press Releases for ACOR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter